Set forth below is a representative list of our recent experience:
- $1.1 billion long/short equity fund focused on public and private healthcare and biotech investments
- $100 million event-driven and special situations fund
- $450 million value-oriented and opportunistic long/short equity and non-corporate credit fund
- $1.1 billion fund of one investing in relative value opportunities within global fixed income markets
- $200 million long/short equity fund
- $300 million fund pursuing a long/short equity strategy focusing on public and private healthcare companies
- $100 million corporate credit focused hedge fund
- $50 million long/short equity fund
- $70 million carbon credit focused hedge fund
- $100 million long-biased, healthcare focused equity fund
- $120 million long/short equity and corporate credit fund
- $30 million long/short equity, healthcare focused fund
- $100 million public equities fund
- $100 million global capital markets focused fund investing in interest rates, credit and currencies